Bioinformatics challenges for personalized medicine
نویسندگان
چکیده
منابع مشابه
Bioinformatics challenges for personalized medicine
MOTIVATION Widespread availability of low-cost, full genome sequencing will introduce new challenges for bioinformatics. RESULTS This review outlines recent developments in sequencing technologies and genome analysis methods for application in personalized medicine. New methods are needed in four areas to realize the potential of personalized medicine: (i) processing large-scale robust genomi...
متن کاملTranslational Bioinformatics Support for Personalized and Systems Medicine: Tasks and Challenges
The current challenges in healthcare including the high costs and high rates of Adverse Drug Reactions (ADRs) call for fundamental changes in both drug development and clinical practice [1,2]. The “onesize-fits-all” drugs ignoring individual differences are often the causes of the ADRs. Paper-based and non-standardized clinical systems have also contributed to errors and adverse events. At the ...
متن کاملMedBioinformatics: Developing Integrative Bioinformatics Applications for Personalized Medicine.
Progress in healthcare and biomedical research involves taking advantage of the huge amount of clinical data and biological knowledge that already exists and is currently being generated. Bioinformatic methods and tools have become essential for data extraction, management, and integration. However, it is necessary to overcome two barriers: the deficit of integrative computational approaches th...
متن کاملChallenges in Nuclear Medicine: Innovative Theranostic Tools for Personalized Medicine
Over the past few years, nuclear medicine has undergone impressive growth with the development of positron emission tomography (PET), especially using 18Ffluoro-deoxy-glucose (18FDG), and new approaches in targeted radionuclide therapy. These developments pave the way for personalized medicine by offering practical solutions, especially in oncology, neurology, and cardiology. Novel radiopharmac...
متن کاملPersonalized medicine for lung cancer: new challenges for pathology.
Recent advances in non-small-cell lung cancer (NSCLC) therapy mean the relatively simple discrimination between small-cell and 'non-small-cell' carcinoma is insufficient to determine the best treatment for individual patients. Safety, efficacy and prescribing requirements mandate more specific subtyping of NSCLC for several new drugs: practice made difficult by the tumour heterogeneity combined...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Bioinformatics
سال: 2011
ISSN: 1460-2059,1367-4803
DOI: 10.1093/bioinformatics/btr295